Assessment of cost-effective changes to the current and potential provision of smoking cessation services: an analysis based on the EQUIPTMOD
- PMID: 29430762
- PMCID: PMC6033165
- DOI: 10.1111/add.14093
Assessment of cost-effective changes to the current and potential provision of smoking cessation services: an analysis based on the EQUIPTMOD
Abstract
Background and aims: Increasing the reach of smoking cessation services and/or including new but effective medications to the current provision may provide significant health and economic benefits; the scale of such benefits is currently unknown. The aim of this study was to estimate the cost-effectiveness from a health-care perspective of viable national level changes in smoking cessation provision in the Netherlands and England.
Methods: A Markov-based state transition model [European study on Quantifying Utility of Investment in Protection from Tobacco model (EQUIPTMOD)] was used to estimate costs and benefits [expressed in quality-adjusted life years (QALY)] of changing the current provision of smoking cessation programmes in the Netherlands and England. The changes included: (a) increasing the reach of top-level services to increase potential quitters (e.g. brief physician advice); (b) increasing the reach of behavioural support (group-based therapy and SMS text-messaging support) to increase the success rates; (c) including a new but effective medication (cytisine); and (d) all changes implemented together (combined change). The costs and QALYs generated by those changes over 2, 5, 10 years and a life-time were compared with that of the current practice in each country. Results were expressed as incremental net benefit (INB) and incremental cost-effectiveness ratio (ICER). A sequential analysis from a life-time perspective was conducted to identify the optimal change.
Results: The combined change was dominant (cost-saving) over all alternative changes and over the current practice, in both countries. The combined change would generate an incremental net benefit of €11.47 (2 years) to €56.16 (life-time) per smoker in the Netherlands and €9.96 (2 years) to €60.72 (life-time) per smoker in England. The current practice was dominated by all alternative changes.
Conclusion: Current provision of smoking cessation services in the Netherlands and England can benefit economically from the inclusion of cytisine and increasing the reach of brief physician advice, text-messaging support and group-based therapy.
Keywords: Cost-effectiveness; cytisine; economic evaluation; public health; return on investment; smoking cessation.
© 2018 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.
Figures
Similar articles
-
Cost-effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD.Addiction. 2018 Jun;113 Suppl 1(Suppl Suppl 1):65-75. doi: 10.1111/add.14090. Epub 2018 Mar 13. Addiction. 2018. PMID: 29532966 Free PMC article.
-
Is it cost-effective to provide internet-based interventions to complement the current provision of smoking cessation services in the Netherlands? An analysis based on the EQUIPTMOD.Addiction. 2018 Jun;113 Suppl 1(Suppl Suppl 1):87-95. doi: 10.1111/add.14069. Epub 2017 Dec 15. Addiction. 2018. PMID: 29243351 Free PMC article.
-
Cost-effectiveness of possible future smoking cessation strategies in Hungary: results from the EQUIPTMOD.Addiction. 2018 Jun;113 Suppl 1(Suppl Suppl 1):76-86. doi: 10.1111/add.14089. Epub 2018 Jan 25. Addiction. 2018. PMID: 29368363 Free PMC article.
-
The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.Tob Use Insights. 2015 Jul 14;8:1-35. doi: 10.4137/TUI.S15628. eCollection 2015. Tob Use Insights. 2015. PMID: 26242225 Free PMC article. Review.
-
Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis.Health Technol Assess. 2012;16(38):1-205, iii-v. doi: 10.3310/hta16380. Health Technol Assess. 2012. PMID: 23046909 Review.
Cited by
-
Effectiveness of nicotine salt vapes, cytisine, and a combination of these products, for smoking cessation in New Zealand: protocol for a three-arm, pragmatic, community-based randomised controlled trial.BMC Public Health. 2023 Sep 11;23(1):1760. doi: 10.1186/s12889-023-16665-w. BMC Public Health. 2023. PMID: 37697327 Free PMC article.
-
The Association of Stage 1 Hypertension, Defined by the 2017 ACC/AHA Guidelines, With Cardiovascular Events Among Rural Women in Liaoning Province, China.Front Cardiovasc Med. 2021 Aug 12;8:710500. doi: 10.3389/fcvm.2021.710500. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34458337 Free PMC article.
-
Cytisine versus varenicline for smoking cessation in New Zealand indigenous Māori: a randomized controlled trial.Addiction. 2021 Oct;116(10):2847-2858. doi: 10.1111/add.15489. Epub 2021 May 4. Addiction. 2021. PMID: 33761149 Free PMC article. Clinical Trial.
-
Cytisine versus varenicline for smoking cessation for Māori (the indigenous people of New Zealand) and their extended family: protocol for a randomized non-inferiority trial.Addiction. 2019 Feb;114(2):344-352. doi: 10.1111/add.14449. Epub 2018 Nov 9. Addiction. 2019. PMID: 30276931 Free PMC article.
References
-
- World Health Organization (WHO) report on the global tobacco epidemic, 2013 enforcing bans on tobacco advertising, promotion and sponsorship [internet]. Geneva: World Health Organization; 2013. [cited 2016 April 20]. Available at: http://site.ebrary.com/id/10931319 (accessed 30 June 2016) (Archived at http://www.webcitation.org/6u5iQDpfP on 9 October 2017).
-
- World Health Organization (WHO) framework convention on tobacco control [internet]. Geneva, Switzerland: World Health Organization; 2003. Available at: http://apps.who.int/iris/bitstream/10665/42811/1/9241591013.pdf (accessed 30 June 2016) (Archived at http://www.webcitation.org/6u5iTZLnI on 9 October 2017).
-
- Joossens L, Raw M. The tobacco control scale 2013 in Europe [internet]. Association of European Cancer Leagues; 2014. Available at: http://www.europeancancerleagues.org/images/TobaccoControl/TCS_2013_in_E... (accessed on 30 June 2016) (Archived at http://www.webcitation.org/6u5iX19bB on 9 October 2017).
-
- Health Survey England 2013 [internet]. Health and Social Care Information Centre; 2014. December. Available at: http://www.hscic.gov.uk/catalogue/PUB16076 (accessed 30 June 2016) (Archived at http://www.webcitation.org/6u5iZpnRC on 9 October 2017).
-
- Statistics on Smoking, England [internet]. Health and Social Care Information Centre; 2006. Available at: https://data.gov.uk/dataset/statistics_on_smoking_england (accessed 30 June 2016) (Archived at http://www.webcitation.org/6u5idnVXR on 9 October 2017).
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
